Investors in biotech companies approach their investments with the mindset of praying or scratching a lottery ticket because the success rate of new drug development is extremely low, and the costs ...

AI can accelerate drug discovery, clinical development, and patient access, but regulatory hurdles remain. Anders Romare, ...

Amid growing concerns over drug abuse, cultism, and electoral violence, the Centre for Peace and Environmental Justice (CEPEJ-Africa) has unveiled its 2026 strategic plan aimed at promoting ...

Variant Bio, a genomics-driven AI drug discovery company, today announced the appointment of Craig T. Basson, MD, PhD, as Chief Medical Officer and President of R&D. Dr. Basson brings more than 25 ...

Hopstem has already completed phase 1 testing of hNPC01 in China, with encouraging results, and says it has now reached ...

Our End-of-Phase 2 meeting with FDA was productive and provided Lexicon with the insights needed to design a robust Phase 3 program, with the goal of making the first non-opioid DPNP medicine ...

Nestled in the Pegasus Park complex in Dallas, a globally recognized center for life science innovation, business and social ...

Researchers from New England Biolabs (NEB®) and Yale University describe the first fully synthetic bacteriophage engineering ...